Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
M2ES 30mg
DRUG
2 trials
Sponsors
Protgen Ltd
Conditions
Advanced Solid Tumors
Pancreatic Cancer
Phase 1
Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer
NCT01218880
Protgen Ltd
Pancreatic Cancer
Start: 2010-06-30
End: 2011-12-31
Target: 21
Updated: 2010-10-19
Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors
NCT01226030
Protgen Ltd
Advanced Solid Tumors
Start: 2009-09-30
End: 2011-06-30
Target: 24
Updated: 2010-10-21